Inventor
BLUEMLING GREGORY R
US15 patents
⚠️ This page may combine multiple inventors who share the name “BLUEMLING GREGORY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV EMORY
14 patentsUS10683319B2Jun 16, 2020
Phosphoramidates for the treatment of hepatitis B virus
UNIV EMORY4 citations83
US10149859B2Dec 11, 2018
Nucleotide and nucleoside therapeutic compositions and uses related thereto
UNIV EMORY6 citations83
US11331331B2May 17, 2022
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY4 citations82
US11981699B2May 14, 2024
Phosphoramidates for the treatment of hepatitis B virus
UNIV EMORY2 citations72
US11166973B2Nov 9, 2021
Substituted nucleotides and nucleosides for treating viral infections
UNIV EMORY2 citations72
US11364257B2Jun 21, 2022
Phosphoramidates for the treatment of hepatitis B virus
UNIV EMORY2 citations68
US10874683B2Dec 29, 2020
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY6 citations68
US12414961B2Sep 16, 2025
Substituted nucleosides and nucleotides for treating viral infections
UNIV EMORY0 citations62
US11857560B2Jan 2, 2024
Pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections
UNIV EMORY0 citations62
US11447518B2Sep 20, 2022
Phosphoramidates for the treatment of hepatitis B virus
UNIV EMORY0 citations62
US12551497B2Feb 17, 2026
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY0 citations61
US12329770B2Jun 17, 2025
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY0 citations61
US11903959B2Feb 20, 2024
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY0 citations61
US11628181B2Apr 18, 2023
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UNIV EMORY0 citations61